BIOPOR (BIOPOR) News
Follow BIOPOR (BIOPOR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Unlocking the Growth - Invitation to BioPorto’s investor meeting on October 7
September 28, 2026News releaseUnlocking the Growth - Invitation to BioPorto’s investor meeting on October 7As BioPorto continues to advance its commercial strategy and capitalize on emerging clinical opportunities, we in
NEWS | Sep 28, 2026, 06:28 AM UTC
L
Reminder: Register Now | Unlocking the Growth - BioPorto Investor Meeting, October 7
September 24, 2026News releaseReminder: Register Now | Unlocking the Growth - BioPorto Investor Meeting, October 7As BioPorto continues to advance its commercial strategy and capitalize on emerging clinical opportunities
NEWS | Sep 24, 2026, 07:21 AM UTC
M
BioPorto enrolls first patient in U.S. Adult NGAL validation
BioPorto enrolled the first patient in its U.S. Adult Urine NGAL Validation Study for ProNephro AKI, targeting about 900 ICU patients across multiple sites to support a potential U.S. adult indication.
EQUITY | Sep 16, 2026, 06:51 AM UTC